NO952781D0 - Potensiering av temozolomid i humane tumorceller - Google Patents

Potensiering av temozolomid i humane tumorceller

Info

Publication number
NO952781D0
NO952781D0 NO952781A NO952781A NO952781D0 NO 952781 D0 NO952781 D0 NO 952781D0 NO 952781 A NO952781 A NO 952781A NO 952781 A NO952781 A NO 952781A NO 952781 D0 NO952781 D0 NO 952781D0
Authority
NO
Norway
Prior art keywords
potentialization
temozolomide
tumor cells
human tumor
human
Prior art date
Application number
NO952781A
Other languages
English (en)
Other versions
NO952781L (no
Inventor
John Colin Baer
Azadeh Alison Freeman
Edward Stuart Newlands
Amanda Jean Watson
Joseph Anthony Rafferty
Geoffrey Paul Margison
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of NO952781D0 publication Critical patent/NO952781D0/no
Publication of NO952781L publication Critical patent/NO952781L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
NO952781A 1993-01-14 1995-07-13 Potensiering av temozolomid i humane tumorceller NO952781L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US475493A 1993-01-14 1993-01-14
PCT/GB1994/000065 WO1994015615A1 (en) 1993-01-14 1994-01-13 Potentiation of temozolomide in human tumour cells

Publications (2)

Publication Number Publication Date
NO952781D0 true NO952781D0 (no) 1995-07-13
NO952781L NO952781L (no) 1995-09-13

Family

ID=21712364

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952781A NO952781L (no) 1993-01-14 1995-07-13 Potensiering av temozolomid i humane tumorceller

Country Status (20)

Country Link
EP (2) EP0679086A1 (no)
JP (1) JPH08505615A (no)
KR (1) KR100352046B1 (no)
CN (1) CN1277541C (no)
AU (1) AU5838494A (no)
CA (1) CA2153775C (no)
CZ (1) CZ286550B6 (no)
FI (1) FI953423A (no)
HU (1) HUT72665A (no)
IL (1) IL108328A (no)
MX (1) MX9400434A (no)
MY (1) MY116474A (no)
NO (1) NO952781L (no)
PL (1) PL175842B1 (no)
RU (1) RU2148401C1 (no)
SK (1) SK282452B6 (no)
TW (1) TW414710B (no)
UA (1) UA29466C2 (no)
WO (1) WO1994015615A1 (no)
ZA (1) ZA94248B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731304A (en) * 1982-08-23 1998-03-24 Cancer Research Campaign Technology Potentiation of temozolomide in human tumour cells
US5942247A (en) * 1996-07-31 1999-08-24 Schering Corporation Method for treating pediatric high grade astrocytoma including brain stem glioma
US5939098A (en) * 1996-09-19 1999-08-17 Schering Corporation Cancer treatment with temozolomide
WO2000033823A2 (en) * 1998-12-07 2000-06-15 Schering Corporation Methods of using temozolomide in the treatment of cancers
US6251886B1 (en) 1998-12-07 2001-06-26 Schering Corporation Methods of using temozolomide in the treatment of cancers
US6635677B2 (en) 1999-08-13 2003-10-21 Case Western Reserve University Methoxyamine combinations in the treatment of cancer
US6465448B1 (en) 1999-08-13 2002-10-15 Case Western Reserve University Methoxyamine potentiation of temozolomide anti-cancer activity
CA2476494C (en) * 2002-02-22 2010-04-27 Schering Corporation Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
WO2003101474A1 (en) * 2002-05-31 2003-12-11 Transmolecular, Inc. Combination chemotherapy with chlorotoxin
CN100350974C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 一种抗癌药物组合物
CN100350975C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 抗癌药物组合物
CN100402091C (zh) * 2005-02-03 2008-07-16 山东蓝金生物工程有限公司 一种抗癌药物组合物
CN100431605C (zh) * 2005-02-03 2008-11-12 山东蓝金生物工程有限公司 一种抗癌药物组合物
GB0502573D0 (en) * 2005-02-08 2005-03-16 Topotarget As Therapeutic compounds
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
JP2011520914A (ja) 2008-05-15 2011-07-21 トランスモレキュラー， インコーポレイテッド 転移腫瘍の処置
HUE034119T2 (en) 2010-02-04 2018-01-29 Morphotek Inc Chlorotoxin polypeptides and conjugates and their use
WO2011142858A2 (en) 2010-05-11 2011-11-17 Fred Hutchinson Cancer Research Center Chlorotoxin variants, conjugates, and methods for their use
CN103169664B (zh) * 2011-12-25 2015-04-22 复旦大学 一种rgd肽修饰的双层载药纳米粒及其制备方法
BR112015013525A2 (pt) 2012-12-10 2017-11-14 Hutchinson Fred Cancer Res método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof

Also Published As

Publication number Publication date
UA29466C2 (uk) 2000-11-15
SK282452B6 (sk) 2002-02-05
IL108328A0 (en) 1994-04-12
CZ179795A3 (en) 1996-04-17
MX9400434A (es) 1994-07-29
CN1277541C (zh) 2006-10-04
CA2153775C (en) 2000-11-14
ZA94248B (en) 1994-07-13
PL175842B1 (pl) 1999-02-26
FI953423A (fi) 1995-08-23
TW414710B (en) 2000-12-11
RU2148401C1 (ru) 2000-05-10
MY116474A (en) 2004-02-28
PL309915A1 (en) 1995-11-13
WO1994015615A1 (en) 1994-07-21
NO952781L (no) 1995-09-13
HUT72665A (en) 1996-05-28
EP0679086A1 (en) 1995-11-02
AU5838494A (en) 1994-08-15
CN1117711A (zh) 1996-02-28
EP0922458A1 (en) 1999-06-16
HU9502117D0 (en) 1995-09-28
KR100352046B1 (ko) 2003-09-03
IL108328A (en) 2010-05-31
SK89295A3 (en) 1996-06-05
CZ286550B6 (cs) 2000-05-17
CA2153775A1 (en) 1994-07-21
FI953423A0 (fi) 1995-07-13
JPH08505615A (ja) 1996-06-18
KR960700063A (ko) 1996-01-19

Similar Documents

Publication Publication Date Title
NO952781D0 (no) Potensiering av temozolomid i humane tumorceller
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
PT1028954E (pt) Imidazoles substituidos uteis no tratamento de doencas inflamatorias
FI954416A (fi) Kehon solujen stimulointi elektromagneettisen säteilyn avulla
IL126768A0 (en) Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
DK295190D0 (da) Kosmetik- og hudbehandlingssammensaetninger
LV11465A (lv) Heterocikliski amidini panemiens to iegusanai un pielietojums
ATE198275T1 (de) Subkutane implantate bestehend aus nomgestrolderivaten
DE69230654D1 (de) Commiphora-Mukul-Extrakte und deren therapeutische Verwendung
DE69331105T2 (de) Verwendung von thioureleyne und thiabendazol in auto immunbedingten und entzündlichen hauterkrankungen
EE03439B1 (et) Teraapias kasutatavad bitsüklilised isotiokarbamiidi derivaadid
FI945829A0 (fi) Ihmisen hemoglobiinin valmistaminen transgeenisissa sioissa
NO992818L (no) Anvendelse av pereddiksyre i fiskeoppdrett
NO970257L (no) Bestemmelse av tonisk ovarie-östrogen sekresjon i utvidede terapeutiske regimer
DE59306085D1 (de) Haar- und körperbehandlungsmittel
NO20010044L (no) Anvendelse av texafyriner i makrofag-medierte sykdommer
SE9203886D0 (sv) Moebel- och skaapstomme
DE69323582D1 (de) Jungaal ähnliches Artifizielles Nahrungsmittel
NO903629D0 (no) Beskyttelse mot spredning av underlivssykdommer i boblebad
AU6371198A (en) Potentiation of temozolomide in human tumour cells
IT1266980B1 (it) Stimolatore cardiaco artificiale
LV5035A3 (lv) Preparats govju endometritu profilaksei un arstesanai
NO920961D0 (no) Hud- og saarpleiemiddel
FI924955A (fi) Expressionsvektorer och anvaendning av dessa foer producering av maenniskans HIV-resistenta celler foer terapeutiska aendmaol
DK168788D0 (da) Kosmetisk hudbehandling

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application